Correction: Comparative efficacy and safety of seven Chinese patent medicines combined with SSRIs for depressive disorder: a systematic review and network meta-analysis - Summary - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Erratum: A Systematic Review and Network Meta-Analysis of the Efficacy and Safety of Seven Chinese Patent Medicines in Combination with SSRIs for Treating Depressive Disorders

  • By

  • Hongye Geng

  • Lixuan Li

  • Chengyuan Lu

  • Shuling Wang

  • September 4, 2026

Share

Objective:

To correct errors in the presentation of data in the original systematic review and network meta-analysis.

Approach:
  • Correction Details: The correction addresses an error in Table 1, which failed to clearly display the comparator group 'SSRIs monotherapy' and did not include mean differences for certain interventions.
Key Findings:
  • The corrected table enhances readability and supports accurate interpretation of the network meta-analysis.
  • Numerical values in the corrected table remain unchanged from the original analysis.
Interpretation:

The correction does not alter the study’s findings or conclusions.

Conclusion:

The original version of the article has been updated with the corrected table.

Sources:

Original Source(s)

Related Content